Ferric citrate for the treatment of hyperphosphatemia and anemia in patients with chronic kidney disease: a meta-analysis of randomized clinical trials
出版年份 2022 全文链接
标题
Ferric citrate for the treatment of hyperphosphatemia and anemia in patients with chronic kidney disease: a meta-analysis of randomized clinical trials
作者
关键词
-
出版物
RENAL FAILURE
Volume 44, Issue 1, Pages 1112-1122
出版商
Informa UK Limited
发表日期
2022-08-01
DOI
10.1080/0886022x.2022.2094273
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Iron Therapy in Chronic Kidney Disease: Days of Future Past
- (2021) Kuo-Hua Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin
- (2021) Mark R. Hanudel et al. KIDNEY INTERNATIONAL
- Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
- (2020) Elizabeth Katherine Batchelor et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ferric citrate in the management of hyperphosphatemia and iron deficiency anemia: A meta‐analysis in patients with chronic kidney disease
- (2020) Yeo Jin Choi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease
- (2020) Charles Ginsberg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2020) Michael G. Shlipak et al. KIDNEY INTERNATIONAL
- The Key Role of Phosphate on Vascular Calcification
- (2019) Mario Cozzolino et al. Toxins
- A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD
- (2019) Geoffrey A. Block et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study
- (2019) Keitaro Yokoyama et al. Scientific Reports
- The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
- (2019) Brian Czaya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients
- (2018) Noriaki Maruyama et al. AMERICAN JOURNAL OF NEPHROLOGY
- Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?
- (2017) Francesco Locatelli et al. JOURNAL OF NEPHROLOGY
- Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
- (2017) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease
- (2017) Glenn M. Chertow et al. PLoS One
- Phosphate binders in chronic kidney disease: a systematic review of recent data
- (2016) Jürgen Floege JOURNAL OF NEPHROLOGY
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- The role of phosphate in kidney disease
- (2016) Marc G. Vervloet et al. Nature Reviews Nephrology
- Ferric Citrate in Patients With Chronic Kidney Disease
- (2016) Geoffrey A. Block SEMINARS IN NEPHROLOGY
- Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
- (2016) Nathan R. Hill et al. PLoS One
- The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial
- (2015) Peter N. Van Buren et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
- (2015) Geoffrey A. Block et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
- (2015) K. Umanath et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
- (2015) Roger A. Rodby et al. Drugs in research & development
- Mechanistic and regulatory aspects of intestinal iron absorption
- (2014) Sukru Gulec et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
- (2014) K. Yokoyama et al. Clinical Journal of the American Society of Nephrology
- Coupling fibroblast growth factor 23 production and cleavage
- (2014) Myles Wolf et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study
- (2014) Chien-Te Lee et al. JOURNAL OF NEPHROLOGY
- Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis
- (2014) J. B. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs
- (2014) Roger Rodby et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis
- (2013) K. Yokoyama et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Oral JTT-751 (Ferric Citrate) on Hyperphosphatemia in Hemodialysis Patients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Keitaro Yokoyama et al. AMERICAN JOURNAL OF NEPHROLOGY
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease
- (2011) C. M. O'Seaghdha et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting
- (2011) C. A. O'Callaghan et al. BMJ Open
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started